Savant is aware that health is people’s most valuable asset, and seeks to provide patients with drugs that allow them to enjoy a better quality of life.
At only 20 years of age, it has become a company of international renown that works every day to offer more health and a better life to millions of people, from Argentina to the rest of the world. This achievement has been possible due to the excellence and determination of their staff, made up of more than 350 workers from different areas. Having a production based on international quality standards, extraordinary technological skills, a manufacturing facility equipped with leading-edge technology and strategically located corporate headquarters, they strive to attain a maximum-efficiency industrial and business process.
SAVANT has a model manufacturing plant, located in a 110,000-m² area in the town of El Tío, Córdoba, Argentina, where proprietary drugs in various pharmaceutical forms are produced: solid (tablets, film-coated tablets, and capsules), semi-solid (soft capsules and granules), and liquid (syrups, suspensions). The company also has a dedicated facility for producing antibiotics in solid dosage forms, such as film-coated tablets and extemporaneous compounding with beta-lactam active ingredients and clavulanic acid combinations, and a soft capsule facility with a capacity of 150,000 units per hour, being among the most important plants of these characteristics in the country.
Address
Esteban Echeverria 1050
Vicente Lopez
Buenos Aires B1602ABC
Argentina
(+54) 11 4730 4606
A roundup of some of the latest stories coming out of Latin American pharma and healthcare, including Merck’s new distribution centre in Brazil; the region’s record dengue surge; Roemmers Laboratory’s…
Writing in the July 2023 edition of DIA’s Global Forum magazine, Mariana Abdala of Crystal Research outlines the vast room for improvement in Latin America’s clinical trial output, the region’s…
Japanese-headquartered Takeda has been undergoing a transformation in recent years, becoming the global leader in rare diseases with the acquisition of Shire in 2018 and divesting ‘non-core’ assets in OTC…
Argentinian generics manufacturer Grupo Roemmers – which celebrated its 100-year anniversary in 2021 – has expanded steadily across the Latin America and Caribbean region since the mid-1970s with a successful…
While Bayer’s recent history has been dominated by the controversial Monsanto acquisition, the German firm will be hoping for a more straightforward next few years with a new leadership team…
Argentinian generics manufacturer Grupo Roemmers – which celebrated its 100-year anniversary in 2021 – has expanded steadily across the Latin America and Caribbean region since the mid-1970s with a successful…
Axios International has been designing and implementing access to healthcare solutions in collaboration with the pharmaceutical industry and other healthcare players across Latin America (LatAm), Europe, the Middle East, Africa,…
Maria Gabriela Pittis, Head of SAM (South Cone, Andean Region, Mexico & Central America and Caribbean) at Takeda, outlines the company’s significant presence in the cluster, its double digit growth…
Florencia Davel, head of LatAm operations for Bristol Myers Squibb (BMS) looks back on a successful four years in position, shaping the regional organisation into a true biopharma player in…
The Head of Viatris Latin America, Patrick Doyle, spoke to PharmaBoardroom about setting up the two-year old company’s Latam affiliate during the pandemic, the decision to focus on specific therapeutic…
Boehringer Ingelheim’s managing director for South America, Dirk van Niekerk, provides an overview of the healthcare climate in South America, the challenges tied to political and economic instability, future opportunities…
Dr Guillermo Chantada, incoming president-elect of the International Society of Paediatric Oncology (SIOP) highlights the progress of paediatric oncology in Latin America and gives a call to arms to the…
See our Cookie Privacy Policy Here
